Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

5,662 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CREB3 suppresses hepatocellular carcinoma progression by depressing AKT signaling through competitively binding with insulin receptor and transcriptionally activating RNA-binding motif protein 38.
He Y, Han S, Li H, Wu Y, Jia W, Chen Z, Pan Y, Cai N, Wen J, Li G, Liang J, Zhao J, Liu Q, Liang H, Ding Z, Huang Z, Zhang B. He Y, et al. Among authors: jia w. MedComm (2020). 2024 Jul 1;5(7):e633. doi: 10.1002/mco2.633. eCollection 2024 Jul. MedComm (2020). 2024. PMID: 38952575 Free PMC article.
Bone Lesion-Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5-Targeting miR-3190-5p.
Han S, Xue L, Wei Y, Yong T, Jia W, Qi Y, Luo Y, Liang J, Wen J, Bie N, Liang H, Liu Q, Ding Z, Yang X, Gan L, Huang Z, Chen X, Zhang B. Han S, et al. Among authors: jia w. Adv Sci (Weinh). 2023 Jun;10(17):e2207080. doi: 10.1002/advs.202207080. Epub 2023 Apr 25. Adv Sci (Weinh). 2023. PMID: 37096833 Free PMC article.
Targeting macrophage metabolism to enhance tumor immunotherapy.
Liu J, Ma Z, Jia W, Lan P. Liu J, et al. Among authors: jia w. Cell Mol Immunol. 2024 May;21(5):530-532. doi: 10.1038/s41423-024-01149-7. Epub 2024 Apr 17. Cell Mol Immunol. 2024. PMID: 38632383 No abstract available.
5,662 results